MET and embryonal carcinoma: Notably, c-MET availability and activation has been related to resistance to radio- and chemotherapy in different cancer types [7,22,38,39]; therefore, it is conceivable to hypothesize that c-MET receptor activation could lead to refractory disease in embryonal carcinoma as well.